656 related articles for article (PubMed ID: 11441526)
1. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
Costantino S; Millozzi F; Scarlata S
Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
[No Abstract] [Full Text] [Related]
2. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
Pichler M; Klein W; Huber K; Pachinger O
Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension in patients with cardiac hypertrophy].
Kohno M
Nihon Rinsho; 2004 Mar; 62 Suppl 3():471-7. PubMed ID: 15171418
[No Abstract] [Full Text] [Related]
5. [AT1 angiotensin receptor inhibition as a new therapeutic possibility].
Hunyady L; Nagy L
Orv Hetil; 1997 Oct; 138(41):2583-90. PubMed ID: 9411327
[TBL] [Abstract][Full Text] [Related]
6. AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions.
Willenheimer R; Dahlöf B; Rydberg E; Erhardt L
Eur Heart J; 1999 Jul; 20(14):997-1008. PubMed ID: 10381851
[No Abstract] [Full Text] [Related]
7. [Clinical efficacy of losartan: are there any differences between angiotensin II type I receptor antagonists and other drugs?].
Redon J; Ferrario CM
Med Clin (Barc); 2000; 114 Suppl 1():23-8. PubMed ID: 10812571
[No Abstract] [Full Text] [Related]
8. [Medical angiotensin II-receptor blockade in hypertension and heart failure].
van Zwieten PA; Lie KI
Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1529-33. PubMed ID: 7675129
[No Abstract] [Full Text] [Related]
9. [Angiotensin II AT1 receptor antagonists: clinical development and future perspectives].
Burnier M; Brunner HR
Therapie; 1998; 53(3):279-84. PubMed ID: 9773127
[TBL] [Abstract][Full Text] [Related]
10. [Debate concerning the optimal blockage of the renin-angiotensin system].
Choukroun G
Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
[No Abstract] [Full Text] [Related]
11. [Losartan--a nonpeptide antagonist of angiotensin-II receptors in the treatment of heart failure].
Berezin AE; Fushteĭ IM
Klin Med (Mosk); 1998; 76(7):12-5. PubMed ID: 9742770
[No Abstract] [Full Text] [Related]
12. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
13. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors].
Berger D
Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712087
[No Abstract] [Full Text] [Related]
14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibitors or AT(1) receptor blockers in heart failure?
Rydén L
Eur Heart J; 1999 Sep; 20(18):1287-9. PubMed ID: 10462459
[No Abstract] [Full Text] [Related]
16. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease.
Weber MA
Rev Cardiovasc Med; 2002; 3(4):183-91. PubMed ID: 12556752
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic role of RAS blockade in chronic heart failure.
Werner CM; Böhm M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor blockers and congestive heart failure.
Auer JW; Berent R; Eber B
Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
[No Abstract] [Full Text] [Related]
19. Are angiotensin II receptor antagonists indicated in chronic heart failure?
Komajda M
Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
Davie AP; Rumley A; Lowe GD; McMurray JJ
Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
[No Abstract] [Full Text] [Related]
[Next] [New Search]